Solid Biosciences Inc.
SLDB
$7.26
$0.212.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -174.33M | -167.14M | -154.08M | -139.68M | -124.70M |
| Total Depreciation and Amortization | 1.64M | 1.66M | 1.69M | 2.54M | 2.46M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.22M | 24.54M | 25.56M | 22.97M | 19.38M |
| Change in Net Operating Assets | -6.82M | 8.56M | 4.22M | 7.50M | 2.85M |
| Cash from Operations | -156.29M | -132.38M | -122.62M | -106.67M | -100.01M |
| Capital Expenditure | -1.15M | -792.00K | -722.00K | -631.00K | -654.00K |
| Sale of Property, Plant, and Equipment | 85.00K | 5.00K | 5.00K | 5.00K | 5.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -57.39M | -66.11M | -31.90M | -4.43M | -15.44M |
| Cash from Investing | -58.45M | -66.90M | -32.62M | -5.06M | -16.09M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -723.00K | -648.00K | -525.00K | -608.00K | -473.00K |
| Issuance of Common Stock | 196.85M | 198.57M | 200.53M | 205.84M | 128.02M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.68M | -1.68M | -1.68M | -306.00K | -5.11M |
| Cash from Financing | 194.45M | 196.24M | 198.32M | 204.92M | 122.44M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.30M | -3.04M | 43.09M | 93.20M | 6.34M |